Luptakova Katarina
SEC insider (Form 3/4/5 filer). CIK 0001991149. CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc. (XLO). 15 reported Form 4/5 transactions since Sep 2024; latest on Jan 1, 2026. Located in WALTHAM, MA.
Companies Luptakova Katarina has filed insider reports for
- Xilio Therapeutics, Inc. (XLO): Officer, CHIEF MEDICAL OFFICER
Luptakova Katarina
CIK: 0001991149
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xilio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jan 1, 2026XLO
Xilio Therapeutics, Inc.
ExerciseDirect16.6K shares- - Dec 31, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
451.9K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
44.2K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44.2K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
15K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
625K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
106K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
106K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
35K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc. | Exercise | 16,625 | - | $0 | Direct |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 451,885 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 44,210 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 44,210 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 15,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 15,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 625,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 106,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 106,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 35,000 | - | - | Direct |
1-10 of 15 transactions